Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Strasbourg, France | OTHER |
| Centre Hospitalier Universitaire Dijon | OTHER |
| Centre Hospitalier Universitaire de Besancon | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cognitive disorders are well-known in multiple sclerosis (MS), even in earlier stages of the disease. They effect personal life. Their management may be overlooked. The evidence-based program proposes exercises to both stimulate preserved functions and develop new abilities compensating for cognitive disabilities.
Aim of the study is to evaluate the efficiency of the remedial program (PROCOG-SEP) designed for MS patients, compared to an interactive discussion program(DISINT) 140 multiple sclerosis patients will be randomly assigned in one the program for 13 sessions over a 6-month period.
Main outcome criteria is evolution of SRT-LIST before and after program.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| procog | Experimental | cognitive remedial program 13 sessions over a 6-month period |
|
| DISINT | Placebo Comparator | Interactive discussion program of 13 group sessions in a 6-month period |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| procog | Other | 3 to 5 people group program |
| |
| Placebo |
| Measure | Description | Time Frame |
|---|---|---|
| cognitive function measured by SRT-List score | 0-9 months |
| Measure | Description | Time Frame |
|---|---|---|
| quality of life measured by MusiQol | 0 -9 months |
| Measure | Description | Time Frame |
|---|---|---|
| cognitive function: verbal memory (SRT), visuospatial memory (10/36), verbal fluency (animal categories),empans, code ,DO80, cognitive complaint | 0-9 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marc DEBOUVERIE, Professor | Central Hospital, Nancy, France | Principal Investigator |
| Eric BERGER, MD | CHU DE BESANCON | Principal Investigator |
| Thibaut MOREAU, Professor | Centre Hospitalier Universitaire Dijon | Principal Investigator |
| Jérôme de Sèze, Professor | CHU de STRASBOURG | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University hospital Nancy | Recruiting | Nancy | 54000 | France |
Not provided
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Other |
|
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |